US Advises Firms on Better Drug Safety Monitoring (Reuters)
Reuters - U.S. health officials gave drug
companies suggestions on Thursday on ways to improve safety
evaluations of medicines during early-stage development and
after they are on the market.
Stumble It!
Tweet This
Bookmark on Delicious
Share on Facebook
Share on MySpace